Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
JAMA. 2021 Feb 16;325(7):658-668. doi: 10.1001/jama.2021.0247.
Pregnancy may be a key window to optimize cardiovascular health (CVH) for the mother and influence lifelong CVH for her child.
To examine associations between maternal gestational CVH and offspring CVH.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study (examinations: July 2000-April 2006) and HAPO Follow-Up Study (examinations: February 2013-December 2016). The analyses included 2302 mother-child dyads, comprising 48% of HAPO Follow-Up Study participants, in an ancillary CVH study. Participants were from 9 field centers across the United States, Barbados, United Kingdom, China, Thailand, and Canada.
Maternal gestational CVH at a target of 28 weeks' gestation, based on 5 metrics: body mass index, blood pressure, total cholesterol level, glucose level, and smoking. Each metric was categorized as ideal, intermediate, or poor using pregnancy guidelines. Total CVH was categorized as follows: all ideal metrics, 1 or more intermediate (but 0 poor) metrics, 1 poor metric, or 2 or more poor metrics.
Offspring CVH at ages 10 to 14 years, based on 4 metrics: body mass index, blood pressure, total cholesterol level, and glucose level. Total CVH was categorized as for mothers.
Among 2302 dyads, the mean (SD) ages were 29.6 (2.7) years for pregnant mothers and 11.3 (1.1) years for children. During pregnancy, the mean (SD) maternal CVH score was 8.6 (1.4) out of 10. Among pregnant mothers, the prevalence of all ideal metrics was 32.8% (95% CI, 30.6%-35.1%), 31.7% (95% CI, 29.4%-34.0%) for 1 or more intermediate metrics, 29.5% (95% CI, 27.2%-31.7%) for 1 poor metric, and 6.0% (95% CI, 3.8%-8.3%) for 2 or more poor metrics. Among children of mothers with all ideal metrics, the prevalence of all ideal metrics was 42.2% (95% CI, 38.4%-46.2%), 36.7% (95% CI, 32.9%-40.7%) for 1 or more intermediate metrics, 18.4% (95% CI, 14.6%-22.4%) for 1 poor metric, and 2.6% (95% CI, 0%-6.6%) for 2 or more poor metrics. Among children of mothers with 2 or more poor metrics, the prevalence of all ideal metrics was 30.7% (95% CI, 22.0%-40.4%), 28.3% (95% CI, 19.7%-38.1%) for 1 or more intermediate metrics, 30.7% (95% CI, 22.0%-40.4%) for 1 poor metric, and 10.2% (95% CI, 1.6%-20.0%) for 2 or more poor metrics. The adjusted relative risks associated with 1 or more intermediate, 1 poor, and 2 or more poor (vs all ideal) metrics, respectively, in mothers during pregnancy were 1.17 (95% CI, 0.96-1.42), 1.66 (95% CI, 1.39-1.99), and 2.02 (95% CI, 1.55-2.64) for offspring to have 1 poor (vs all ideal) metrics, and the relative risks were 2.15 (95% CI, 1.23-3.75), 3.32 (95% CI,1.96-5.62), and 7.82 (95% CI, 4.12-14.85) for offspring to have 2 or more poor (vs all ideal) metrics. Additional adjustment for categorical birth factors (eg, preeclampsia) did not fully explain these significant associations (eg, relative risk for association between 2 or more poor metrics among mothers during pregnancy and 2 or more poor metrics among offspring after adjustment for an extended set of birth factors, 6.23 [95% CI, 3.03-12.82]).
In this multinational cohort, better maternal CVH at 28 weeks' gestation was significantly associated with better offspring CVH at ages 10 to 14 years.
妊娠可能是优化母亲心血管健康(CVH)并影响其子女终生 CVH 的关键窗口。
研究母体妊娠期 CVH 与后代 CVH 之间的关联。
设计、地点和参与者:这项队列研究使用了 Hyperglycemia and Adverse Pregnancy Outcome(HAPO)研究(检查:2000 年 7 月至 2006 年 4 月)和 HAPO 随访研究(检查:2013 年 2 月至 2016 年 12 月)的数据。分析包括来自美国、巴巴多斯、英国、中国、泰国和加拿大的 9 个现场中心的 2302 对母婴对子,这些参与者构成了 HAPO 随访研究的 48%。
根据 5 项指标(体重指数、血压、总胆固醇水平、血糖水平和吸烟),在妊娠 28 周时评估母体妊娠 CVH。每项指标均根据妊娠指南分为理想、中间或不良。总 CVH 分为以下几类:所有理想指标、1 个或多个中间(但没有 1 个不良)指标、1 个不良指标或 2 个或更多不良指标。
在 10 至 14 岁的儿童中评估后代 CVH,基于 4 项指标:体重指数、血压、总胆固醇水平和血糖水平。总 CVH 的分类与母亲相同。
在 2302 对母子中,孕妇的平均(SD)年龄为 29.6(2.7)岁,儿童的平均(SD)年龄为 11.3(1.1)岁。在妊娠期间,孕妇 CVH 评分的平均(SD)为 8.6(1.4)分。在孕妇中,所有理想指标的患病率为 32.8%(95%CI,30.6%-35.1%)、31.7%(95%CI,29.4%-34.0%)有 1 个或多个中间指标、29.5%(95%CI,27.2%-31.7%)有 1 个不良指标,以及 6.0%(95%CI,3.8%-8.3%)有 2 个或更多不良指标。在所有理想指标母亲的孩子中,所有理想指标的患病率为 42.2%(95%CI,38.4%-46.2%)、1 个或多个中间指标的患病率为 36.7%(95%CI,32.9%-40.7%)、1 个不良指标的患病率为 18.4%(95%CI,14.6%-22.4%)、2 个或更多不良指标的患病率为 2.6%(95%CI,0%-6.6%)。在有 2 个或更多不良指标的母亲的孩子中,所有理想指标的患病率为 30.7%(95%CI,22.0%-40.4%)、1 个或多个中间指标的患病率为 28.3%(95%CI,19.7%-38.1%)、1 个不良指标的患病率为 30.7%(95%CI,22.0%-40.4%)、2 个或更多不良指标的患病率为 10.2%(95%CI,1.6%-20.0%)。与母亲妊娠期间有 1 个或多个中间、1 个不良或 2 个或更多不良(与所有理想)指标相关的调整后相对风险分别为 1.17(95%CI,0.96-1.42)、1.66(95%CI,1.39-1.99)和 2.02(95%CI,1.55-2.64),后代有 1 个不良(与所有理想)指标,相对风险为 2.15(95%CI,1.23-3.75)、3.32(95%CI,1.96-5.62)和 7.82(95%CI,4.12-14.85),后代有 2 个或更多不良(与所有理想)指标。进一步调整分类出生因素(例如,先兆子痫)并不能完全解释这些显著关联(例如,母亲妊娠期间有 2 个或更多不良指标与后代有 2 个或更多不良指标之间关联的调整后相对风险为 6.23[95%CI,3.03-12.82])。
在这项多国队列研究中,妊娠 28 周时更好的母体 CVH 与 10 至 14 岁儿童的更好的后代 CVH 显著相关。